Considerations for Developing Saliva-based Lateral Flow Immunoassays

By Fortis Life Sciences LLC

Lateral flow assays (LFAs) designed for diagnostic applications at home (over-the-counter, OTC) and point-of-care (PoC) are simple to use and can test for a wide variety of biomarkers in a diverse set of matrices including saliva, nasal swabs, blood, and urine.

The demand for rapid SARS-CoV-2 testing drove worldwide familiarity with the use of LFAs in OTC and PoC settings, bringing increased attention to sample type and collection method.

To read more, please download this free white paper.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Sections

Sections

Sections

Sections

Sections